论文部分内容阅读
慢性肝炎的分型目前国内外较为一致,即分为慢性活动性肝炎(以下简称“慢活肝”),与慢性迁延性肝炎(下称“慢迁肝”)或称慢性持续性肝炎两种。两者在应用调整免疫功能药物治疗的选择上却截然不向。慢活肝主要采用免疫抑制药物,如皮质激素、硫唑嘌呤、6MP等治疗,而慢迁肝则宜用细胞免疫促发剂治疗。本文就我院近几年来应用新的免疫药物治疗慢性肝炎的疗效报道如下。
The classification of chronic hepatitis is more consistent at home and abroad, that is divided into chronic active hepatitis (hereinafter referred to as “slow living liver”), and chronic persistent hepatitis (hereinafter referred to as “slowly moving liver”) or chronic persistent hepatitis . Both of them have no choice in the application of medication for adjusting immune function. Slow-living liver mainly immunosuppressive drugs, such as corticosteroids, azathioprine, 6MP and other treatment, while the slow-moving liver should be treated with cellular immune initiator. This article on our hospital in recent years the application of new immunotherapeutic drugs for the treatment of chronic hepatitis reported as follows.